샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786721

세계의 하이드로겔 기반 약물전달 시스템 시장

Hydrogel-based Drug Delivery Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 290 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

하이드로겔 기반 약물전달 시스템 세계 시장은 2030년까지 216억 달러에 이를 전망

2024년에 153억 달러로 추정되는 하이드로겔 기반 약물전달 시스템 세계 시장은 2024-2030년간 CAGR 5.9%로 성장하여 2030년에는 216억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 천연은 CAGR6.1%를 나타내고, 분석 기간 종료까지 123억 달러에 이를 것으로 예측됩니다. 합성 부문의 성장률은 분석 기간중 CAGR 5.9%로 추정됩니다.

미국 시장은 42억 달러로 추정, 중국은 CAGR 9.3%로 성장 예측

미국의 하이드로겔 기반 약물전달 시스템 시장은 2024년에는 42억 달러에 이를 것으로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 44억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.3%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 2.9%와 5.8%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.8%를 나타낼 전망입니다.

세계의 하이드로겔 기반 약물전달 시스템 시장 - 주요 동향과 촉진요인 정리

하이드로겔 기반 시스템이 현대 약물 전달의 게임 체인저가 될 수 있는 이유는 무엇인가?

하이드로겔 기반 약물 전달 시스템은 정밀의료 진화의 초석으로 등장하여 제어된 표적 치료 전달을 위한 첨단 플랫폼을 제공합니다. 이러한 친수성 고분자 네트워크는 생체 적합성, 높은 수분 함량, 자연 조직 환경을 모방한 조절 가능한 물리적 특성으로 인해 가치가 높습니다. 중요한 차별화 요소는 pH, 온도, 효소 등 다양한 생리적 자극에 반응하는 능력에 있으며, 이를 통해 부위 특이적 약물 방출과 치료 효과를 향상시킬 수 있습니다. 최근 스마트 하이드로겔 및 나노복합 하이드로겔과 같은 새로운 하이드로겔 제제는 특히 종양, 안과 및 상처 치료 응용 분야에서 약물의 유지 시간과 반응성을 개선하도록 설계되었습니다. 혁신이 주도하는 이 분야는 치료의 패러다임을 재구성하고, 개인화된 저침습적이고 효율적인 치료 옵션을 제공합니다.

바이오 메디컬 응용 분야 급증의 촉매제는 혁신인가?

하이드로겔은 약물 전달에 그치지 않고 다양한 의료 응용 분야에서 유용성을 발견하고 있으며, 헬스케어 분야에서 전략적 가치를 높이고 있습니다. 조직공학 비계, 재생의료, 진단 시스템 등에 하이드로겔을 사용하는 것은 그 다양성을 잘 보여주고 있습니다. 특히 주사용 하이드로겔은 전신 노출을 최소화하고 국소적이고 지속적인 약물 전달을 제공함으로써 수술 후 회복과 만성 질환 관리에 혁명을 일으키고 있습니다. 하이드로겔은 종양 부위에 화학요법제의 직접 전달을 용이하게 하고 독성을 감소시키는 등 암 치료에 있어 획기적인 발전이 이루어지고 있습니다. 또한, 하이드로겔 기술과 생체 전자 장치의 통합은 실시간 치료 피드백 시스템을 가능하게 하여 개인 맞춤형 의료에서 진단과 치료의 가교 역할을 하고 있습니다. 이러한 분야 간 응용을 통해 하이드로겔 기술은 의료 혁신의 주류로 올라서고 있습니다.

규제와 조사 생태계는 어떻게 시장의 궤도를 형성하고 있는가?

지지적인 규제와 강력한 연구 이니셔티브는 하이드로겔 기반 약물 전달 시스템의 상업적 잠재력을 크게 가속화하고 있습니다. 하이드로겔 제제를 개선하고 생물학적 제제, 펩타이드, 유전자 치료와의 시너지 효과를 모색하기 위해 전 세계적으로 정부 및 학술 기관의 연구개발 투자가 증가하고 있습니다. FDA의 생체재료 승인에 대한 유연한 태도는 스타트업과 제약회사들이 새로운 하이드로겔 시스템을 시장에 출시하는 데 소요되는 리드 타임을 단축할 수 있는 길을 더욱 열어주고 있습니다. 또한, 이 분야의 특허 활동은 증가 추세에 있으며, 임상 연구 중인 하이드로겔 유효 치료제의 강력한 파이프라인이 있습니다. 이와 함께, 특히 북미와 아시아태평양에서 산학협력 혁신 생태계가 조성되고 있으며, 이들 지역은 첨단 하이드로겔 기술 개발의 핫스팟으로 떠오르고 있습니다. 이러한 요소들은 제품 파이프라인을 풍부하게 할 뿐만 아니라, 공정의 최적화와 확장성을 통해 비용 절감에도 기여하고 있습니다.

여러 치료 분야에서 시장 확대가 가속화되고 있는 이유는 무엇일까?

하이드로겔 기반 약물 전달 시스템 시장의 성장은 기술 발전, 이용 사례 확대, 소비자 기대치의 변화를 반영하는 몇 가지 요인에 의해 주도되고 있습니다. 환자 중심의 비침습적 치료법에 대한 수요 증가는 하이드로겔의 국소적이고 지속적인 약물 투여 능력과 일치합니다. 하이드로겔 매트릭스 3D 프린팅, 마이크로플루이딕스 지원 약물 캡슐화 등의 기술 개선으로 생산이 더욱 효율적이고 맞춤화할 수 있게 되었습니다. 종양학, 정형외과, 피부과 등 최종 사용자 분야에서는 하이드로겔의 정확성과 적응성으로 인해 하이드로겔을 이용한 치료법 채택이 증가하고 있습니다. 또한, 인구 고령화와 만성질환의 확산으로 인해 장시간 작용하는 주사 시스템 및 이식형 전달 장치에 대한 수요가 증가하고 있습니다. 소비자 행동의 관점에서 볼 때, 개인화되고 사용하기 쉬운 약물 전달 솔루션에 대한 선호도가 증가하고 있으며, 이는 시장 수요를 더욱 촉진하고 있습니다. 라틴아메리카와 동남아시아의 신흥 시장에서도 의료비 지출이 증가하고 있으며, 하이드로겔 기술 시장 침투가 진행되고 있습니다.

부문

폴리머 기원(천연, 합성, 하이브리드), 투여 경로(피하, 눈, 구강, 국소, 기타)

조사 대상 기업 예

  • 3M Company
  • AD Surgical
  • Aquestive Therapeutics Inc.
  • ARx LLC
  • Ashland
  • AstraZeneca Plc.
  • Bausch & Lomb
  • BioDelivery Sciences International Inc.
  • Blairex Laboratories Inc.
  • Coloplast A/S
  • Ferring B.V.
  • Johnson & Johnson
  • Medtronic
  • Micropore Technologies
  • Neurelis, Inc.
  • Ocular Therapeutix, Inc.
  • Pfizer, Inc.
  • ProLynx Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals, Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해 시장과 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.14

Global Hydrogel-based Drug Delivery Systems Market to Reach US$21.6 Billion by 2030

The global market for Hydrogel-based Drug Delivery Systems estimated at US$15.3 Billion in the year 2024, is expected to reach US$21.6 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Natural, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the Synthetic segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 9.3% CAGR

The Hydrogel-based Drug Delivery Systems market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Hydrogel-Based Drug Delivery Systems Market - Key Trends & Drivers Summarized

What Makes Hydrogel-Based Systems a Game-Changer in Modern Drug Delivery?

Hydrogel-based drug delivery systems have emerged as a cornerstone in the evolution of precision medicine, offering an advanced platform for controlled and targeted therapeutic delivery. These hydrophilic polymer networks are prized for their biocompatibility, high water content, and tunable physical properties, which mimic natural tissue environments. A key differentiator lies in their capacity to respond to various physiological stimuli-such as pH, temperature, and enzymes-allowing for site-specific drug release and enhanced therapeutic efficacy. Over recent years, novel hydrogel formulations such as smart hydrogels and nanocomposite hydrogels have been engineered to improve drug retention time and responsiveness, especially in oncological, ophthalmic, and wound care applications. This innovation-driven sector is reshaping treatment paradigms, offering personalized, minimally invasive, and efficient therapeutic options.

Is Innovation the Catalyst Behind the Surge in Biomedical Applications?

Hydrogels have found extensive utility across a wide spectrum of medical applications beyond drug delivery, reinforcing their strategic value in the healthcare sector. Their use in tissue engineering scaffolds, regenerative medicine, and diagnostic systems highlights their versatility. In particular, injectable hydrogels are revolutionizing post-surgical recovery and chronic disease management by providing localized, sustained drug delivery with minimal systemic exposure. This advancement is notably evident in cancer therapeutics, where hydrogels facilitate the direct delivery of chemotherapeutic agents to tumor sites, reducing toxicity. Additionally, the integration of hydrogel technologies with bioelectronic devices is enabling real-time therapeutic feedback systems, creating a bridge between diagnostics and therapy in personalized medicine. Such cross-disciplinary applications are pushing hydrogel technologies into the mainstream of medical innovation.

How Are Regulatory and Research Ecosystems Shaping Market Trajectories?

Supportive regulatory pathways and robust research initiatives are significantly accelerating the commercial viability of hydrogel-based drug delivery systems. Governments and academic institutions globally are increasingly investing in R&D to improve hydrogel formulations and explore their synergistic use with biologics, peptides, and gene therapies. The FDA’s flexible stance on biomaterial approvals has further paved the way for startups and pharma giants alike to bring novel hydrogel systems to market with reduced lead times. Moreover, patent activity in this domain is on the rise, with a strong pipeline of hydrogel-enabled therapeutics under clinical investigation. In parallel, academic-industry collaborations are fostering innovation ecosystems, particularly in North America and Asia-Pacific, which are becoming hotspots for advanced hydrogel technology development. These factors are not only enhancing product pipelines but are also driving down costs through process optimization and scalability.

Why Is Market Expansion Accelerating Across Multiple Therapeutic Frontiers?

The growth in the hydrogel-based drug delivery systems market is driven by several factors that reflect a convergence of technological advances, expanding end-use cases, and shifting consumer expectations. The rising demand for patient-centric, non-invasive treatment modalities is aligning with hydrogel capabilities in localized and sustained drug administration. Technological improvements such as 3D printing of hydrogel matrices and microfluidic-assisted drug encapsulation are making production more efficient and customizable. End-user sectors like oncology, orthopedics, and dermatology are increasingly adopting hydrogel-based therapies due to their precision and adaptability. Additionally, aging populations and the prevalence of chronic diseases are increasing the demand for long-acting injectable systems and implantable delivery devices. From a consumer behavior standpoint, there is a growing preference for personalized, easy-to-use drug delivery solutions, further propelling market demand. Emerging markets in Latin America and Southeast Asia are also witnessing a rise in healthcare spending, enabling broader market penetration of hydrogel technologies.

SCOPE OF STUDY:

The report analyzes the Hydrogel-based Drug Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Polymer Origin (Natural, Synthetic, Hybrid); Administration Route (Subcutaneous, Ocular, Oral Cavity, Topical, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • 3M Company
  • AD Surgical
  • Aquestive Therapeutics Inc.
  • ARx LLC
  • Ashland
  • AstraZeneca Plc.
  • Bausch & Lomb
  • BioDelivery Sciences International Inc.
  • Blairex Laboratories Inc.
  • Coloplast A/S
  • Ferring B.V.
  • Johnson & Johnson
  • Medtronic
  • Micropore Technologies
  • Neurelis, Inc.
  • Ocular Therapeutix, Inc.
  • Pfizer, Inc.
  • ProLynx Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Hydrogel-based Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Demand for Targeted and Controlled Drug Delivery Spurs Growth in Hydrogel-based Systems
    • Growing Prevalence of Chronic Diseases Strengthens Business Case for Long-Acting Drug Delivery Platforms
    • Advancements in Biocompatible Materials Expand Addressable Market Opportunity for Hydrogel-based Formulations
    • Increasing R&D Investment by Pharmaceutical Companies Drives Innovation in Hydrogel-based Therapeutics
    • Rising Adoption of Personalized Medicine Accelerates Demand for Tunable Hydrogel Carriers
    • Expansion of Biologics and Peptide Drug Pipeline Spurs Interest in Hydrogel Delivery Technologies
    • Growing Popularity of Minimally Invasive Therapies Drives Adoption of Injectable Hydrogel Systems
    • Supportive Regulatory Approvals and Fast-Track Designations Sustain Growth Momentum Across Developed Markets
    • Proliferation of 3D Printing in Biomedical Applications Throws the Spotlight on Smart Hydrogels for On-Demand Drug Release
    • Escalating Focus on Patient Compliance and Convenience Generates Demand for Sustained Release Hydrogel Platforms
    • Rising Interest in Nanotechnology Integration Propels Development of Advanced Hydrogel Drug Carriers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hydrogel-based Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Natural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Natural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Natural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Subcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ocular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oral Cavity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oral Cavity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Oral Cavity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제